Scribe Therapeutics Ownership & Insider Activity

Scribe Therapeutics (SCTX) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 6.0% of shares outstanding. Institutional investors hold 14.6%. Over the past 90 days, insiders made 6 purchases worth $71.3M.

Shares Outstanding

18.932M

Insider Shares Owned

1.141M

Insider % Owned

6.0%

Institutional Shares Held

2.567M

Institutional % Held

14.6%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

$71.3M total

Sales (90d)

Net Activity

Net Buying

Net Value (90d)

$71.3M

Scribe Therapeutics Insider Transactions (Last 6 Months)

See all insider trades →

Date	Insider	Title	Type	Shares	Price	Value
Jul 27, 2026	AH Bio Fund II LP, AH Equity Partners Bio II LLC, AH Bio Fund III LP, AH Equity Partners Bio III LLC, Marc Andreessen, BENJAMIN HOROWITZ	10% OWNER	BUY	3.083M	$15.00	$5.0M
Jul 27, 2026	Carl L Gordon	DIRECTOR	BUY	1.349M	$15.00	$15.0M
Jul 27, 2026	ORBIMED ADVISORS LLC, OrbiMed Capital GP VIII LLC	DIRECTOR	BUY	1.349M	$15.00	$15.0M
Jul 24, 2026	Behzad Aghazadeh, Avoro Capital Advisors LLC, Avoro Ventures LLC	DIRECTOR	BUY	2.391M	$15.16	$36.3M
Jul 23, 2026	Svetlana Lucas	CHIEF BUSINESS OFFICER	BUY	3.000K	$15.00	$45K
Jul 23, 2026	David Parrot	CHIEF FINANCIAL OFFICER	BUY	2.666K	$15.00	$40K

More with Benzinga EdgeGet Access

Scribe Therapeutics Inc

Scribe Therapeutics Ownership & Insider Activity

Scribe Therapeutics Insider Transactions (Last 6 Months)

People Also Watch

People Also Watch